Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | USP7 | Q93009 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PLAT | P00750 | 3/20 | 0.31 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | MAP4K3 | Q8IVH8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16615167 | 0.80 | MAP4K3 (0.31) | JAK2MAP4K3 | |
| SCHEMBL20859332 | 0.79 | CHRM1 (0.44) | CHRM1CHRM3USP7NPC1RAB9A | |
| SCHEMBL16615209 | 0.79 | CHRM1 (0.45) | CHRM1CHRM3USP7NPC1RAB9A | |
| SCHEMBL16615265 | 0.78 | NPC1 (0.43) | CHRM1CHRM3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16615365 | 0.77 | PLK4 (0.35) | JAK2 | |
| SCHEMBL16615346 | 0.76 | TSHR (0.35) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16615312 | 0.75 | NR1H4 (0.36) | — | |
| SCHEMBL16615279 | 0.75 | HDAC1 (0.33) | JAK2 | |
| SCHEMBL16615272 | 0.74 | CHRM1 (0.41) | CHRM1CHRM3USP7JAK2 | |
| SCHEMBL20859259 | 0.73 | CHRM1 (0.37) | CHRM1CHRM3USP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015047133-A1 | NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" | 2015-04-02 | — | — | WO | disclosed |